Sec Form 4 Filing - KINGSLEY ALFRED D @ BIOTIME INC - 2013-06-04

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person KINGSLEY ALFRED D 2. Issuer Name and Ticker or Trading Symbol BIOTIME INC [ BTX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner X __ Officer (give title below) _____ Other (specify below) See Remarks (Last) (First) (Middle) 150 E. 57TH STREET 3. Date of Earliest Transaction (MM/DD/YY) 06/04/2013 (Street) NEW YORK, NY10022 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Shares, no par value 06/04/2013 S 320,000 D 6,620,055 ( 2 ) D Common Shares, no par value 1,682,505 I By Greenbelt Corp. Common Shares, no par value 375,351 I By Greenway Partners, LP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Ex ercisable Expiration Date Title Amount or Number of Shares Option to Puchase Common Shares $ 5 06/04/2013 S 80,000 06/04/2013 06/04/2018 Common Shares 80,000 $ 0 0 D Option to Puchase Common Shares $ 4.6 ( 3 ) 06/30/2017 Common Shares 50,000 50,000 D Option to Puchase Common Shares $ 5.13 ( 4 ) 06/30/2016 Common Shares 50,000 50,000 D Option to Puchase Common Shares $ 5.45 ( 5 ) 08/09/2015 Common Shares 50,000 50,000 D Option to Puchase Common Shares $ 2.3 ( 6 ) 07/01/2014 Common Shares 50,000 50,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other KINGSLEY ALFRED D 150 E. 57TH STREET NEW YORK, NY10022 X X See Remarks Signatures /s/ Alfred D. Kingsley 06/06/2013 Signature of Reporting Person Date

Explanation of Responses:

( 1 )On June 4, 2013, Mr. Kingsley sold 320,000 BioTime common shares and 80,000 options to purchase 80,000 common shares in two private transactions. Each common share and one quarter of each option were sold for an aggregate price of $4.155. ( 2 )Does not include shares that Mr. Kingsley may acquire through the exercise of certain options. ( 3 )12,500 options became exercisable on September 30, 2012; 12,500 options became exercisable on December 31, 2012; 12,500 options became exercisable on March 31, 2013; and the remaining 12,500 options will become exercisable on June 30, 2013 based upon continued service on the board of directors. ( 4 )12,500 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012. ( 5 )12,500 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011. ( 6 )12,500 options became exercisable on September 30, 2009; December 31, 2009; March 31, 2010; and June 30, 2010.

Remarks: Mr. Kingsley is Executive Chairman of certain BioTime subsidiaries.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.